Who Paid My Doc
Anna Schweikert
Geriatric Medicine Cincinnati, OH Medical Doctor
NPI 1659733749 CMS profile 4311223
3805 Edwards Rd Ste 360, Cincinnati, OH 45209
General payments
$56
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Anna Schweikert of Cincinnati, OH is reported in the CMS Open Payments database as having received $56 across 3 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 28th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $56 | 3 |
Beside peers
- Anna Schweikert
- Geriatric Medicine median
- Middle half of Geriatric Medicine
- National median
In program year 2025, general payments to Anna Schweikert were reported at $56. Among 512 Geriatric Medicine profiles paid that year, the median was $120 and the middle half received between $37 and $350.
Show as a table
| Year | Anna Schweikert | Geriatric Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $96 | $28–$339 | $163 |
| 2020 | $0 | $99 | $28–$262 | $114 |
| 2021 | $0 | $94 | $27–$318 | $132 |
| 2022 | $0 | $103 | $34–$338 | $149 |
| 2023 | $0 | $109 | $39–$320 | $160 |
| 2024 | $0 | $125 | $36–$371 | $164 |
| 2025 | $56 | $120 | $37–$350 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 117 drugsPart D claims
6,464
Drug cost
$486,063
Branded share of claims
19%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 54 | $78,670 | |
| Jardiance Empagliflozin | Brand | 35 | $45,952 | |
| Prolia Denosumab | Brand | 26 | $45,130 | |
| Eliquis Apixaban | Brand | 43 | $44,403 | |
| Rybelsus Semaglutide | Brand | 40 | $38,265 | |
| Xarelto Rivaroxaban | Brand | 20 | $30,497 | |
| Januvia Sitagliptin Phosphate | Brand | 19 | $29,429 | |
| Farxiga Dapagliflozin Propanediol | Brand | 26 | $21,596 | |
| Myrbetriq Mirabegron | Brand | 23 | $21,031 | |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 25 | $16,440 |
The 10 drugs with the highest cost, of 117 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 35 billing codesPaid by Medicare
$73,312
Medicare patients
316
Services billed
1,940
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 68% | |
| Arthritis | 39% | |
| Osteoporosis | 24% | |
| Ischemic heart disease | 20% | |
| Chronic kidney disease | 20% | |
| Diabetes | 18% | |
| Cancer | 17% | |
| Depression | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Pcv20 vaccine im 90677 | Office | 26 | 26 | $7,493 |
| Vaccine for influenza for injection into muscle 90662 | Office | 77 | 78 | $6,303 |
| Sarscov2 vac 50 mcg/0.5ml im 91322 | Office | 37 | 37 | $5,692 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Geriatric Medicine in Ohio
Related records
Geriatric Medicine in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Geriatric Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.